Mindray Expands Portfolio - Analyst Blog
17 Ottobre 2011 - 4:45PM
Zacks
Mindray Medical
International Limited (MR), a prominent Chinese medical
devices company, recently introduced the A3 anesthesia system,
which extends its A series product lineup. The latest addition is a
platform for anesthesia delivery that adds depth to the company’s
wide array of patient monitoring and ultrasound systems. The new
offerings are being showcased at the American Society of
Anesthesiologists meeting in Chicago, during October 14 and 18,
2011.
Both the A3 and A5 of Mindray’s A
Series portfolio combine operating ease with high-class
performance. Their intuitive design demonstrates practical
sophistication. The touch screen, measuring 15 inches, permits
practitioners to comfortably choose ventilation positions so that
they may dedicate more resources to patient care.
Mindray has utilized open
architecture and chosen profiles in order to improve
interoperability. The A series complies with Integrating the
Healthcare Enterprise - Patient Care Domain profiles.
Mindray is a bellwether in the
Chinese MedTech industry with a solid international presence. It
operates in three segments: Patient Monitoring, In-vitro
Diagnostics and Medical Imaging. A key distinction with domestic
competitors is that the majority of Mindray’s products have CE Mark
and/or Food and Drug Administration (“FDA”) clearance.
Mindray maintains a decent product
pipeline and brings out several new products each year. The company
plans to bring to market 7 to 10 new products in fiscal 2011 after
introducing several new products in fiscal 2010. New products
contribute in a major way to Mindray’s revenues.
The company has entered the premium
segment globally, where its competitive advantage is still unclear.
Also, on the negative side, health care reform, in China and the
U.S., may reduce demand for Mindray’s products. Competition is
fierce and leads to price erosion over time. The company expects
Chinese government tender sales to be a smaller portion of its
domestic revenues.
Mindray’s competitors, in different
niche segments, include General Electric (GE),
Philips (PHG) and Siemens (SI).
We currently have a long-term Neutral rating on the stock.
GENL ELECTRIC (GE): Free Stock Analysis Report
MINDRAY MEDICAL (MR): Free Stock Analysis Report
KONINKLIJKE PHL (PHG): Free Stock Analysis Report
SIEMENS AG-ADR (SI): Free Stock Analysis Report
Zacks Investment Research
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Lug 2023 a Lug 2024